September 07, 2017
1 min read
Save

Trial Scorecard: LICORN

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers examined the effectiveness of levosimendan in patients with low ejection fraction after cardiac surgery.

Trial Scorecard: LICORN